Visgeneer Inc. (4197.TWO)
Taipei Exchange · TWD · Healthcare · Biotechnology
NT$8.32 (+0.00%) as of
Key statistics
- Market cap
- 251.11M
- EPS (TTM)
- -0.13
- Dividend yield
- 0.00%
- 52-week range
- 7.77 – 22.50
- Beta
- 0.13
- Revenue (TTM)
- 170.72M
- Profit margin
- -2.20%
- Volume
- 10.00k
About Visgeneer Inc.
Visgeneer Inc. engages in the provision of health solutions in the fields of medical device, cosmetics and skin care, Zeaxanthin, and cancer gene diagnostics in Europe and Asia. The company offers blood glucose and ketone, uric acid, and cholesterol monitoring systems. It also provides functional masks, such as wood pulp mask, invisible mask, black mask, pure cloth mask, and bio cellulose mask; face cream, night cream, day cream, wrinkle cream, repairing cream, whitening cream, exfoliating cream, toner, and lotions; functional essences; body lotion and spa clay mask; physical blocker, chemical blocker, and comprehensive sun protection; face wash, wash cream, cleaning cleansing mousse, cleaning cleansing gel, shampoo, and body wash; hand cream, knee cream, foot mask, hand mask, and glucosamine cream; anti-acne cream, female private cleaning lotion, skin care, skin capsules, and hair capsules; and customized skin care products. In addition, the company offers eBmonitor Blood Monitoring System, CoreSence Skincare, BOWIL Skincare, angera, ZeaSight EU Patent Zeaxanthin, and Cancer Gene Diagnostics. Visgeneer Inc. was founded in 2005 and is based in Hsinchu City, Taiwan.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Hsinchu City, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.